MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

SLS SELLAS Life Sciences Group Forecast, Technical & Fundamental Analysis

a developer of biopharmaceuticals

Industry Biotechnology
SLS
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For SLS
(Try 14 days for Free)
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SLS
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For SLS
(Try 14 days for Free)
Ad is loading...
A.I. Advisor
published Earnings

SLS is expected to report earnings to -10 cents per share on March 20

SELLAS Life Sciences Group SLS Stock Earnings Reports
Q4'24
Est.
$-0.10
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.02
Q4'23
Missed
by $0.22
The last earnings report on November 13 showed earnings per share of -10 cents, beating the estimate of -12 cents. With 983.88K shares outstanding, the current market capitalization sits at 62.06M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
7 Times Square
Phone
+1 646 200-5278
Employees
16
Web
https://www.sellaslifesciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

SLS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SLS has been loosely correlated with ARGNF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if SLS jumps, then ARGNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLS
1D Price
Change %
SLS100%
-4.17%
ARGNF - SLS
36%
Loosely correlated
N/A
GYRE - SLS
24%
Poorly correlated
+11.31%
AVTE - SLS
22%
Poorly correlated
N/A
CVM - SLS
21%
Poorly correlated
+16.45%
ABVC - SLS
21%
Poorly correlated
-5.59%
More